Schedule of activities | |||||
---|---|---|---|---|---|
Time point | Enrolment | Initial Visit and chemotherapy cycle 1 (Anthracyclines) | Cycle 2–4 (Anthracyclines) | Cycle 5—8 (Taxanes) | Close-out |
Enrolment | |||||
Screening and Informed Consent | X | ||||
Physical Examen | X | X | X | X | |
Clinical Record | X | X | X | X | |
HIV Test and Pregnancy test | X | ||||
Interventions | |||||
Medication dispensing | X | X | X | X | |
Follow-up visit | X | X | X | X | |
Safety Assessment | |||||
Hemogram | X | X | X | X | |
Transaminase AST | X | X | X | X | |
Transaminase ALT | X | X | X | X | |
Alkaline Phosphatase | X | X | X | X | |
Total Bilirubin | X | X | X | X | |
Triglycerides | X | X | X | X | |
Electrocardiograma | X | X | X | ||
Echocardiograma | X | X | X | ||
Efficacy Assessment | |||||
RECISTa | X | X | X | ||
Metabolomea | X | X | X | ||
Microbiome Analysisa | X | X | X | ||
Tumor Infiltratea | X | X | X | ||
Progression-Free Survival | X | ||||
QLQ C-30 Quality of Life Surveys | X | X | X | ||
QLQ BR-23 Quality of Life Surveys | X | X | X |